UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015055
Receipt number R000017519
Scientific Title Taking metformin before a meal prevents postprandial hyperglycemia; a randomized, open-label, crossover pilot study.
Date of disclosure of the study information 2015/08/01
Last modified on 2015/08/03 18:40:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Taking metformin before a meal prevents postprandial hyperglycemia; a randomized, open-label, crossover pilot study.

Acronym

Taking metformin before meal

Scientific Title

Taking metformin before a meal prevents postprandial hyperglycemia; a randomized, open-label, crossover pilot study.

Scientific Title:Acronym

Taking metformin before meal

Region

Japan


Condition

Condition

diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Taking metformin with a meal has been shown to decrease its bioavailability. We hypothesized that taking metformin before a meal improves glucose metabolism.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

postprandial glucose level

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

taking metformin with a meal(1000mg)->wash out->taking metformin 30 minutes before meal(1000mg)

Interventions/Control_2

taking metformin 30 minutes before meal(1000mg)->wash out->taking metformin with a meal(1000mg)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

60 years-old >=

Gender

Male

Key inclusion criteria

We invited patients with type 2 diabetes who were being treated by metformin monotherapy and whose HbA1c was under 6.0% from Hospital of Kyoto Prefectural University of Medicine.

Key exclusion criteria

Allergy to metformin

Target sample size

8


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michiaki Fukui

Organization

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Division name

Department of Endocrinology and Metabolism

Zip code


Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto

TEL

0752515506

Email

sayarinapm@hotmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Muhei Tanaka

Organization

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Division name

Department of Endocrinology and Metabolism

Zip code


Address

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto

TEL

0752515506

Homepage URL


Email

muhei-t@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 10 Month 22 Day

Date of IRB


Anticipated trial start date

2014 Year 10 Month 22 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 09 Month 04 Day

Last modified on

2015 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017519


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name